Dr. Ran Reshef, MD
Claim this profileColumbia University Irving Medical Center
About Ran Reshef, MD
Education:
- Obtained an MD from Columbia University College of Physicians and Surgeons in 2006.
- Completed a Residency in Internal Medicine at NewYork-Presbyterian Hospital/Columbia University Medical Center in 2009.
- Finished a Fellowship in Hematology and Oncology at NewYork-Presbyterian Hospital/Columbia University Medical Center in 2012.
Experience:
- Currently serves as an Assistant Professor of Medicine at Columbia University Irving Medical Center.
- Attending physician at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Area of expertise
Cancer
Ran Reshef, MD has run 7 trials for Cancer. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Ran Reshef, MD has run 4 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Columbia University Irving Medical Center
Columbia University
Clinical Trials Ran Reshef, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting
2 awards
Phase 3
12 criteria
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting
1 award
Phase 2 & 3
More about Ran Reshef, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Ran Reshef, MD has experience with
- Fludarabine
- Cyclophosphamide
- Tabelecleucel
- Lenalidomide
- Idecabtagene Vicleucel
- PBCAR0191
Breakdown of trials Ran Reshef, MD has run
Cancer
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ran Reshef, MD specialize in?
Ran Reshef, MD focuses on Cancer and Non-Hodgkin's Lymphoma. In particular, much of their work with Cancer has involved HLA positive patients, or patients who are HLA-A negative.
Is Ran Reshef, MD currently recruiting for clinical trials?
Yes, Ran Reshef, MD is currently recruiting for 8 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ran Reshef, MD has studied deeply?
Yes, Ran Reshef, MD has studied treatments such as Fludarabine, Cyclophosphamide, Tabelecleucel.
What is the best way to schedule an appointment with Ran Reshef, MD?
Apply for one of the trials that Ran Reshef, MD is conducting.
What is the office address of Ran Reshef, MD?
The office of Ran Reshef, MD is located at: Columbia University Irving Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Irving Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.